期刊文献+

各种组织学分型的卵巢癌患者血清CA-125浓度变化分析

下载PDF
导出
摘要 目的:分析各种组织学分型的卵巢癌患者血清CA-125浓度变化。方法:连续选择近期接受手术治疗的卵巢癌患者110例,治疗前进行血清CA-125标本采集,并根据病理标本的组织学分型特点进行分组,比较CA-125浓度值和阳性率分布情况。结果:高血清CA-125浓度值的组织学分型前3位分别是浆液性囊腺、内膜样肿瘤和性索间质肿瘤的卵巢癌患者,高血清CA-125阳性率的组织学分型前3位分别是浆液性囊腺、内膜样肿瘤和混合性上皮癌(P均<0.05~0.01)。结论:卵巢癌的组织学分型特点与患者血清CA-125表达和阳性率情况有一定关联性。
作者 曾琼
出处 《中国当代医药》 2011年第5期69-70,共2页 China Modern Medicine
  • 相关文献

参考文献7

二级参考文献53

  • 1Lloyd KO,Yin BW,Kudryashov V.Isolation and characterization of ovarian cancer antigen CA125 using a new monoclonal antibody (VK-8):Identification as a mucin-type molecule[J].Int J Cancer,1997,71:842-850.
  • 2Bast Rc Jr,Feeney M,Lazarus H,et al.Reactivity of monoclonal antibody with human ovarian carcinoma[J].J Clin Invest,1981,68:1331-1337.
  • 3Bast Rc Jr,Klug TL,ST john E,et al.A radioimmunoassy using a monoclonal antibody to monitor the course of epithelial ovarian cancer[J].N Engl J Med,1983,309(15):883-887.
  • 4丰有吉.卵巢肿瘤.见:乐杰主编.妇产科学.6版[M].北京:人民卫生出版社,2005,305-316.
  • 5Fures R,Bukovie D,Hodek B,et al.Preoperative tumor marker CA125 levels in relation to epithelial ovarian cancer stage[J].Coll Antropol,1999,231:189-194.
  • 6Saygili U,Guelu S,Uslu T,et al.The effect of ascites,mass volume,and peritoneal carcinomatosis on serum CA125 levels in patients with ovarian carinoma[J].Int J Gynecol Cancer,2002,12(5):438-442.
  • 7Fures R, Bukovic D, Hodek B,et al. Preoperative tumor marker CA125 levels in relation to epithelial ovarian cancer stage.Coll-Antropel, 1999 , 23(1): 189.
  • 8Bilgin T,Karabay A,Dolar E, et al. Peritoneal tuberculosis with pelvic abdominal mass,ascites and elevated CA125 mimicking advanced ovarian carcinoma: a series of 10 cases. Int J Gy-Necol Cancer, 2001,11:290.
  • 9Saygili U, Guclu S, Uslu T, et al. The effect of ascites, mass volume, and peritoneal carcinomatosis on serum CA125 levels in patients with ovarian carcinoma. Int J Gynecol Cancer, 2002, 12(5): 438.
  • 10连利娟.林巧稚妇科肿瘤学(第3版)[M].北京:人民卫生出版社,2001.411.

共引文献66

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部